Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001516928 | SCV001725302 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001516928 | SCV001765661 | likely benign | not provided | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259897 | SCV002539497 | benign | Bohring-Opitz syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488726 | SCV002801956 | likely benign | Bohring-Opitz syndrome; Myelodysplastic syndrome | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001516928 | SCV001931215 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001725171 | SCV001959705 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001725171 | SCV001968204 | benign | not specified | no assertion criteria provided | clinical testing |